5397 |
The New Concept of Guidewire Manipulation in CTO PCI |
Shunsuke Matsuno |
Apr. 08. 22 |
5396 |
Importance of Perpendicular Projections for Guidewire Manipulation |
Katsuyuki Hasegawa |
Apr. 08. 22 |
5395 |
Fundamental Limitations of the Mechanical Guidewire in CTO-PCI |
Kenichiro Shimoji |
Apr. 08. 22 |
5394 |
CTO PCI in CHIP: What¡¯s the Difference? |
Yue Li |
Apr. 08. 22 |
5393 |
Functional Assessment: Is It Necessary in CHIP-PCI? |
Lei Song |
Apr. 08. 22 |
5392 |
Best Device and Innovation Concepts: TCT 2021 & THT 2022 |
Juan F. Granada |
Apr. 08. 22 |
5391 |
Economic Outcomes of TAVR vs SAVR for Low-Risk Patients: Results from the PARTNER 3 Trial |
David Joel Cohen |
Apr. 08. 22 |
5390 |
FAVOR III China: A Sham-controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI |
Bo Xu |
Apr. 08. 22 |
5389 |
iFR-SWEDEHEART: Five-year Outcomes of a Randomized Trial of iFR-guided vs. FFR-guided PCI |
Matthias Gotberg |
Apr. 08. 22 |
5388 |
Clinical Impact of Patient-Prosthesis Mismatch After TAVR |
Duk-Woo Park |
Apr. 08. 22 |